Follow-up of Blood-Pressure Lowering and Glucose Control in Type 2 Diabetes-Reference-Cited by-同舟云学术

Follow-up of Blood-Pressure Lowering and Glucose Control in Type 2 Diabetes

Published:2014-10-09 Issue:15 Volume:371 Page:1392-1406
ISSN:0028-4793
Container-title:New England Journal of Medicine
language:en
Short-container-title:N Engl J Med

Author:

Zoungas Sophia,Chalmers John,Neal Bruce,Billot Laurent,Li Qiang,Hirakawa Yoichiro,Arima Hisatomi,Monaghan Helen,Joshi Rohina,Colagiuri Stephen,Cooper Mark E.,Glasziou Paul,Grobbee Diederick,Hamet Pavel,Harrap Stephen,Heller Simon,Lisheng Liu,Mancia Giuseppe,Marre Michel,Matthews David R.,Mogensen Carl E.,Perkovic Vlado,Poulter Neil,Rodgers Anthony,Williams Bryan,MacMahon Stephen,Patel Anushka,Woodward Mark

Publisher

Massachusetts Medical Society

Subject

General Medicine

Link

http://www.nejm.org/doi/pdf/10.1056/NEJMoa1407963

Cited by 518 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The place of gliclazide MB in modern treatment strategies for patients with type 2 diabetes mellitus;Diabetes mellitus;2024-09-04

2. Combination blood pressure lowering therapy in patients with type 2 diabetes: messages from the ADVANCE trial;Journal of Hypertension;2024-08-27

3. 2023 Clinical Practice Guidelines for Diabetes Management in Korea: Full Version Recommendation of the Korean Diabetes Association;Diabetes & Metabolism Journal;2024-07-31

4. Current Position of Gliclazide and Sulfonylureas in the Contemporary Treatment Paradigm for Type 2 Diabetes: A Scoping Review;Diabetes Therapy;2024-06-27

5. Effect of a multicomponent quality improvement strategy on sustained achievement of diabetes care goals and macrovascular and microvascular complications in South Asia at 6.5 years follow-up: Post hoc analyses of the CARRS randomized clinical trial;PLOS Medicine;2024-06-03